CommercialCoverageMedium impact
Saturation Biopsy for Diagnosis, Staging, and Management of Prostate Cancer
Blue Cross & Blue Shield of Mississippi·MS · Urology, Oncology, Pathology·Medical Policy
We identified it
Jun 20, 2026
Summary
Blue Cross Blue Shield Mississippi updated their policy on saturation biopsy for prostate cancer diagnosis, staging, and management. The policy considers saturation biopsy (20+ core tissue samples) medically necessary for most members, but investigational for Federal Employee Program (FEP) members.
Action Required
Immediately: Billing team must verify patient plan type before submitting saturation biopsy claims using CPT 55706. For Federal Employee Program (FEP) members, obtain prior authorization as the procedure is considered investigational. For all other BCBS Mississippi members, the procedure is considered medically necessary and should process normally. Update billing system notes to flag FEP plans for additional review.